These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12603592)

  • 1. B cell inhibitory receptors and autoimmunity.
    Pritchard NR; Smith KG
    Immunology; 2003 Mar; 108(3):263-73. PubMed ID: 12603592
    [No Abstract]   [Full Text] [Related]  

  • 2. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
    Cornall RJ; Goodnow CC; Cyster JG
    Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649
    [No Abstract]   [Full Text] [Related]  

  • 4. Lyn/CD22/SHP-1 and their importance in autoimmunity.
    Blasioli J; Goodnow CC
    Curr Dir Autoimmun; 2002; 5():151-60. PubMed ID: 11826756
    [No Abstract]   [Full Text] [Related]  

  • 5. [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].
    Tsubata T
    Z Rheumatol; 2016 Feb; 75(1):86-9. PubMed ID: 26830296
    [No Abstract]   [Full Text] [Related]  

  • 6. Siglecs in the immune system.
    Crocker PR; Varki A
    Immunology; 2001 Jun; 103(2):137-45. PubMed ID: 11412300
    [No Abstract]   [Full Text] [Related]  

  • 7. Co-receptors on B lymphocytes.
    Tsubata T
    Curr Opin Immunol; 1999 Jun; 11(3):249-55. PubMed ID: 10375550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD22-directed monoclonal antibody therapy for lymphoma.
    Siegel AB; Goldenberg DM; Cesano A; Coleman M; Leonard JP
    Semin Oncol; 2003 Aug; 30(4):457-64. PubMed ID: 12939714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.
    Rudge EU; Cutler AJ; Pritchard NR; Smith KG
    J Exp Med; 2002 Apr; 195(8):1079-85. PubMed ID: 11956299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperresponsive B cells in CD22-deficient mice.
    O'Keefe TL; Williams GT; Davies SL; Neuberger MS
    Science; 1996 Nov; 274(5288):798-801. PubMed ID: 8864124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
    Fearon DT; Carroll MC
    Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling mutations and autoimmunity.
    Yu CC; Mamchak AA; DeFranco AL
    Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies.
    O'Keefe TL; Williams GT; Batista FD; Neuberger MS
    J Exp Med; 1999 Apr; 189(8):1307-13. PubMed ID: 10209047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-receptors of B lymphocytes.
    O'Rourke L; Tooze R; Fearon DT
    Curr Opin Immunol; 1997 Jun; 9(3):324-9. PubMed ID: 9203413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
    Tsubata T
    Front Immunol; 2018; 9():2276. PubMed ID: 30333834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment.
    Cyster JG; Goodnow CC
    Immunity; 1997 May; 6(5):509-17. PubMed ID: 9175829
    [No Abstract]   [Full Text] [Related]  

  • 20. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
    Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
    J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.